NovaSight
PrivateLast Round
Series B
Mar 1, 2024
Total Funding Raised
$23M
Company Overview
NovaSight is a therapeutic devices company that develops eye-tracking-based solutions for the diagnosis and treatment of pediatric vision disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovaSight Comps
Public and private peers based on sector, stage, and business model.
NovaSight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 1, 2024 | ||||
| Series A | Jul 13, 2020 |
NovaSight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rimonci | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors increased 264% MoM, reaching 8.4K.
- May 2, 2025
Monthly visitors grew 117% MoM, reaching 2.6K.
NovaSight Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NovaSight's valuation, stock price, and market status.
